
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
NOVEL DRUG DELIVERY SYSTEM: A REVIEW ARTICLE
Samta Khillare*, Rushikesh Ghule, S. A. Waghmare and Hemant Kamble
. Abstract In recent years, a more logical approach to the creation of an ideal drug delivery system has been made possible by our growing understanding of the pharmacokinetic and pharmacodynamic behaviour of the medication. It is already apparent that multidisciplinary efforts will contribute significantly to future success in drug delivery research. The use of enhanced drug delivery systems, which are both safer and more effective, represents a step forward in the treatment of many human diseases as well as attractive marketing prospects for pharmaceutical companies. When a drug delivery system is designed properly, the target is met or the desired rate of drug administration is reached or demanded by the physiological needs of the body. Traditional pharmaceutical dosage forms are unable to regulate how quickly drugs are delivered to the target place. The distribution of the drug in non-target tissue and body fluids necessitates therapeutic doses that may be greatly greater than those needed in target cells, and the higher doses frequently result in severe adverse reactions during treatment. Therefore, novel drug delivery systems (NDDS) are those carriers that keep the drug concentration in the therapeutic range for a longer period of time and may also deliver the necessary dosage to the specific site of action as well. Keywords: Drug delivery systems, Bioavailabilty, Therapeutic agent, Diseases, Specific target sites, Body fluids, Non- targeting tissues, Drug etc. [Full Text Article] [Download Certificate] |
